GR861318B - Morphinan derivatives - Google Patents
Morphinan derivativesInfo
- Publication number
- GR861318B GR861318B GR861318A GR860101318A GR861318B GR 861318 B GR861318 B GR 861318B GR 861318 A GR861318 A GR 861318A GR 860101318 A GR860101318 A GR 860101318A GR 861318 B GR861318 B GR 861318B
- Authority
- GR
- Greece
- Prior art keywords
- morphinan derivatives
- morphinan
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3518525 | 1985-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR861318B true GR861318B (en) | 1986-09-19 |
Family
ID=6271435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR861318A GR861318B (en) | 1985-05-23 | 1986-05-21 | Morphinan derivatives |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS61271275A (en) |
AU (1) | AU594954B2 (en) |
BE (1) | BE904796A (en) |
DK (1) | DK240386A (en) |
ES (1) | ES8802318A1 (en) |
FI (1) | FI862124A (en) |
FR (1) | FR2582309B1 (en) |
GB (1) | GB2175898B (en) |
GR (1) | GR861318B (en) |
HU (1) | HU196376B (en) |
IL (1) | IL78872A0 (en) |
IT (1) | IT1203791B (en) |
LU (1) | LU86435A1 (en) |
NL (1) | NL8601188A (en) |
NZ (1) | NZ216250A (en) |
PH (1) | PH23341A (en) |
SE (1) | SE8602308L (en) |
ZA (1) | ZA863873B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
US4863928A (en) * | 1989-01-04 | 1989-09-05 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for arthritic and inflammatory diseases |
US4923875A (en) * | 1989-07-10 | 1990-05-08 | Baker Cummins Pharmaceuticals, Inc. | Method for treatment of mast cell-mediated dermatologic disorders |
JP2906654B2 (en) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | Immunosuppressant and method for producing the same |
US5057322A (en) * | 1990-08-10 | 1991-10-15 | Baker Cummins Dermatologicals, Inc. | Method of treating mast cell disease |
EP0577847B1 (en) | 1992-01-23 | 1998-10-14 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
WO1995003307A1 (en) * | 1993-07-19 | 1995-02-02 | Toray Industries, Inc. | Brain cell protective |
AU686203B2 (en) * | 1993-07-23 | 1998-02-05 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
TR199801348T2 (en) * | 1996-01-10 | 1998-10-21 | Smithkline Beecham S.P.A. | Heterosyclic condensate morphinoid t�revleri (II). |
CN1180844C (en) * | 1996-11-25 | 2004-12-22 | 东丽株式会社 | Antipruritic agent |
AU6117298A (en) * | 1997-07-25 | 1999-02-16 | Toray Industries, Inc. | Hyponatremia remedies |
US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
JP5438250B2 (en) | 2002-05-17 | 2014-03-12 | ジェンケン バイオサイエンスィズ,インコーポレイテッド | Opioids and opioid-like compounds and their use |
US7501433B2 (en) | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
JP4957489B2 (en) * | 2002-10-09 | 2012-06-20 | 東レ株式会社 | Pharmaceutical containing morphinan derivative having nitrogen-containing cyclic substituent or pharmacologically acceptable acid addition salt thereof |
US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US8354534B2 (en) * | 2008-02-14 | 2013-01-15 | Alkermes, Inc. | Selective opioid compounds |
WO2014091295A1 (en) * | 2012-12-14 | 2014-06-19 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
JP6141444B2 (en) * | 2012-12-14 | 2017-06-07 | パーデュー、ファーマ、リミテッド、パートナーシップ | Spirocyclic morphinans and their use |
AR096851A1 (en) * | 2013-07-11 | 2016-02-03 | H Lundbeck As | SALTS THAT DO NOT FORM HYDRATS OR SOLVATOS DE NALMEFENO |
WO2015192053A1 (en) * | 2014-06-13 | 2015-12-17 | Purdue Pharma L.P. | Azamophinan derivatives and use thereof |
-
1986
- 1986-05-09 HU HU861934A patent/HU196376B/en not_active IP Right Cessation
- 1986-05-12 NL NL8601188A patent/NL8601188A/en not_active Application Discontinuation
- 1986-05-19 GB GB8612159A patent/GB2175898B/en not_active Expired
- 1986-05-19 PH PH33785A patent/PH23341A/en unknown
- 1986-05-21 ES ES555200A patent/ES8802318A1/en not_active Expired
- 1986-05-21 FI FI862124A patent/FI862124A/en not_active Application Discontinuation
- 1986-05-21 AU AU57637/86A patent/AU594954B2/en not_active Expired - Fee Related
- 1986-05-21 NZ NZ216250A patent/NZ216250A/en unknown
- 1986-05-21 BE BE1/011493A patent/BE904796A/en not_active IP Right Cessation
- 1986-05-21 IL IL78872A patent/IL78872A0/en unknown
- 1986-05-21 SE SE8602308A patent/SE8602308L/en not_active Application Discontinuation
- 1986-05-21 GR GR861318A patent/GR861318B/en unknown
- 1986-05-22 JP JP61118984A patent/JPS61271275A/en active Pending
- 1986-05-22 DK DK240386A patent/DK240386A/en not_active Application Discontinuation
- 1986-05-22 LU LU86435A patent/LU86435A1/en unknown
- 1986-05-23 ZA ZA863873A patent/ZA863873B/en unknown
- 1986-05-23 FR FR8607367A patent/FR2582309B1/en not_active Expired
- 1986-05-23 IT IT48050/86A patent/IT1203791B/en active
Also Published As
Publication number | Publication date |
---|---|
DK240386A (en) | 1986-11-24 |
ZA863873B (en) | 1988-01-27 |
SE8602308D0 (en) | 1986-05-21 |
HUT41737A (en) | 1987-05-28 |
FI862124A0 (en) | 1986-05-21 |
ES8802318A1 (en) | 1988-05-01 |
GB2175898B (en) | 1989-07-05 |
BE904796A (en) | 1986-11-21 |
JPS61271275A (en) | 1986-12-01 |
IT8648050A0 (en) | 1986-05-23 |
ES555200A0 (en) | 1988-05-01 |
DK240386D0 (en) | 1986-05-22 |
IL78872A0 (en) | 1986-09-30 |
SE8602308L (en) | 1986-11-24 |
IT1203791B (en) | 1989-02-23 |
GB2175898A (en) | 1986-12-10 |
PH23341A (en) | 1989-07-14 |
FR2582309A1 (en) | 1986-11-28 |
LU86435A1 (en) | 1986-12-05 |
NZ216250A (en) | 1990-04-26 |
FI862124A (en) | 1986-11-24 |
FR2582309B1 (en) | 1989-08-18 |
GB8612159D0 (en) | 1986-06-25 |
NL8601188A (en) | 1986-12-16 |
AU594954B2 (en) | 1990-03-22 |
AU5763786A (en) | 1986-11-27 |
HU196376B (en) | 1988-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0191562A3 (en) | Tetrahydrocarbazolone derivatives | |
GB2175898B (en) | Morphinan derivatives | |
GB8620638D0 (en) | Derivatives | |
GB8601292D0 (en) | 13beta-alkylmilbemycin derivatives | |
GB8617292D0 (en) | Poly-4-aminopyyrrole-2-carboxamido derivatives | |
GB8627491D0 (en) | 5-phenyl-2-oxazole derivatives | |
GB2176181B (en) | Aryltetralin derivatives | |
GB8614176D0 (en) | Piperonylcarboxamido derivatives | |
GB2174703B (en) | Pyridinylpiperazine derivatives | |
GB2172286B (en) | Tetraprenylamine derivatives | |
GB2177692B (en) | Diazinylpiperidine derivatives | |
GB8623513D0 (en) | Glucosylmoranoline derivatives | |
GB8520631D0 (en) | Derivatives | |
GB8511892D0 (en) | Fluoralkane derivatives | |
GB8623075D0 (en) | Bicyclocatechol derivatives | |
GB2177695B (en) | Aminoalkylamide derivatives | |
GB8600575D0 (en) | Benzonorbornene derivatives | |
GB2174092B (en) | Eburnamenine derivatives | |
GB2177090B (en) | 10-alpha-methoxy-6-methyl-ergoline derivatives | |
GB8630780D0 (en) | Estradiene derivatives | |
GB8508422D0 (en) | Punaglandin derivatives | |
GB8630781D0 (en) | Estrene derivatives | |
GB8527320D0 (en) | Flavolignan derivatives | |
GB8609591D0 (en) | Pyridazodiazepine derivatives | |
IE850044L (en) | Pyrrolidinylalkylaminopyridine derivatives |